{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-20",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "third_party_flag": "Y",
      "life_sustain_support_flag": "N",
      "gmp_exempt_flag": "N",
      "summary_malfunction_reporting": "Eligible",
      "product_code": "PAF",
      "openfda": {
        "registration_number": [
          "2025560",
          "3003834021"
        ],
        "fei_number": [
          "2025560",
          "3002808039"
        ],
        "k_number": [
          "K111956"
        ]
      },
      "review_panel": "IM",
      "medical_specialty": "IM",
      "device_name": "Voltage Gated  Calcium Channel (Vgcc) Antibody Assay",
      "review_code": "",
      "unclassified_reason": "",
      "medical_specialty_description": "Immunology",
      "device_class": "2",
      "definition": "Intended for semi-quantitative determination of VGCC Antibody in human serum. The VGCC Ab may be present in patients diagnosed with Lambert-Eaton Syndrome (LEMS). The assay result is not to be used alone and to be used in conjunction with other clinical, electrodiagnostic and laboratory findings.",
      "regulation_number": "866.5660",
      "implant_flag": "N",
      "submission_type_id": "1"
    }
  ]
}